FOXO TECHNOLOGIES INC. Files Q2 2024 10-Q
Ticker: FOXOW · Form: 10-Q · Filed: Aug 19, 2024 · CIK: 1812360
Sentiment: neutral
Topics: 10-Q, quarterly-report, financials
TL;DR
FOXO files Q2 10-Q. Financials updated.
AI Summary
FOXO TECHNOLOGIES INC. filed its 10-Q for the period ending June 30, 2024. The company, formerly Delwinds Insurance Acquisition Corp., is based in Minneapolis, MN. This filing covers the second quarter of 2024 and provides financial updates for the company.
Why It Matters
This 10-Q filing provides investors with the latest financial performance and operational details for FOXO TECHNOLOGIES INC. during the second quarter of 2024.
Risk Assessment
Risk Level: medium — The filing is a standard quarterly report, but the company's specific financial health and market position are not detailed enough in this header to assess risk definitively.
Key Numbers
- Q2 2024 — Reporting Period (Covers the second quarter of 2024.)
- 20240630 — As of Date (Financials are reported as of this date.)
Key Players & Entities
- FOXO TECHNOLOGIES INC. (company) — Filer
- Delwinds Insurance Acquisition Corp. (company) — Former Company Name
- 20240630 (date) — Period of Report
- 20240819 (date) — Filing Date
- MINNEAPOLIS, MN (location) — Business Address
FAQ
What is the primary business of FOXO TECHNOLOGIES INC.?
The filing lists the SIC code as SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731], indicating a focus on research services.
When did FOXO TECHNOLOGIES INC. change its name?
The company changed its name from Delwinds Insurance Acquisition Corp. on 20200518.
What is the fiscal year end for FOXO TECHNOLOGIES INC.?
The fiscal year ends on December 31st.
What is the SEC file number for FOXO TECHNOLOGIES INC.?
The SEC file number is 001-39783.
What is the business address of FOXO TECHNOLOGIES INC.?
The business address is 729 WASHINGTON AVE. N, SUITE 600, MINNEAPOLIS, MN 55401.
Filing Stats: 4,774 words · 19 min read · ~16 pages · Grade level 19 · Accepted 2024-08-19 08:05:58
Key Financial Figures
- $0.0001 — ered: Class A Common Stock, par value $0.0001 FOXO NYSE American Indicate by ch
Filing Documents
- form10-q.htm (10-Q) — 1406KB
- ex10-1.htm (EX-10.1) — 96KB
- ex31-1.htm (EX-31.1) — 20KB
- ex31-2.htm (EX-31.2) — 20KB
- ex32-1.htm (EX-32.1) — 9KB
- 0001493152-24-032961.txt ( ) — 7776KB
- foxo-20240630.xsd (EX-101.SCH) — 62KB
- foxo-20240630_cal.xml (EX-101.CAL) — 73KB
- foxo-20240630_def.xml (EX-101.DEF) — 282KB
- foxo-20240630_lab.xml (EX-101.LAB) — 489KB
- foxo-20240630_pre.xml (EX-101.PRE) — 389KB
- form10-q_htm.xml (XML) — 1130KB
- FINANCIAL INFORMATION
PART I - FINANCIAL INFORMATION: Item 1.
Financial Statements
Financial Statements 1 Unaudited Condensed Consolidated Balance Sheets as of June 30, 2024 and December 31, 2023 1 Unaudited Condensed Consolidated Statements of Operations for the Three and Six Months Ended June 30, 2024 and 2023 2 Unaudited Condensed Consolidated Statements of Changes in Stockholders' (Deficit) Equity for Each of the Quarters in the Six Months Ended June 30, 2024 and 2023 3 Unaudited Condensed Consolidated Statements of Cash Flows for the Six Months Ended June 30, 2024 and 2023 5 Notes to Unaudited Condensed Consolidated Financial Statements 6 Item 2.
Management's Discussion and Analysis of Financial Condition and Results of Operations
Management's Discussion and Analysis of Financial Condition and Results of Operations 32 Item 3.
Quantitative and Qualitative Disclosures About Market Risk
Quantitative and Qualitative Disclosures About Market Risk 44 Item 4.
Controls and Procedures
Controls and Procedures 45
- OTHER INFORMATION
PART II - OTHER INFORMATION: Item 1.
Legal Proceedings
Legal Proceedings 46 Item 5. Other Information 46 Item 6. Exhibits 46
SIGNATURES
SIGNATURES 47 i SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS AND OTHER INFORMATION CONTAINED IN THIS REPORT This Quarterly Report on Form 10-Q, or this Report, and the documents incorporated herein by reference contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), which include, without limitation, statements regarding estimates and forecasts of financial and performance metrics, projections of market opportunity and market share, potential benefits and the commercial attractiveness to its customers of our products and services, the potential success of our marketing and expansion strategies, realization of the potential benefits of the Business Combination (including with respect to stockholder value and other aspects of our business identified in this Report), as well as other reports that we file from time to time with the Securities and Exchange Commission. Any statements about our business, financial results, financial condition and operations contained in this Report that are not statements of historical fact may be deemed to be forward-looking statements. These forward-looking statements represent our intentions, plans, expectations, assumptions and beliefs about future events and are subject to risks, uncertainties and other factors. Without limiting the foregoing, the words "believes," "anticipates," "expects," "intends," "plans," "projects," or similar expressions are intended to identify forward-looking statements. We undertake no obligation to update publicly any forward-looking statements for any reason, except as required by law, even as new information becomes available or other events occur in the future. Our actual results could differ materially from those expressed or implied by these forward-looking statements as a result of various factors, including the risk fac